Risk Stratification in Nonischemic Dilated Cardiomyopathy Using CMR Imaging: A Systematic Review and Meta-Analysis

Christian Eichhorn1,2,3, David Koeckerling4, Rohin K Reddy5,6

  • 1Division of Acute Medicine, University Hospital Basel, Basel, Switzerland.

JAMA
|September 19, 2024
PubMed
Summary

Accurate risk stratification for nonischemic dilated cardiomyopathy (NIDCM) is challenging. Cardiac magnetic resonance (CMR) imaging, particularly late gadolinium enhancement (LGE), significantly predicts adverse outcomes, while left ventricular ejection fraction (LVEF) shows limited prognostic value.